Rigel Pharmaceuticals (RIGL) Enterprise Value (2010 - 2026)
Rigel Pharmaceuticals' quarterly Enterprise Value came in at -$146.7 million in Q1 2026, down 90.25% year-on-year from -$1.5 billion in Q1 2025, and up 5.34% quarter-over-quarter from -$155.0 million in Q4 2025.
Rigel Pharmaceuticals has reported Enterprise Value for 17 years, with the latest figure at -$146.7 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 90.25% year-over-year to -$146.7 million; the trailing twelve-month figure through Mar 2026 stood at -$146.7 million (down 90.25% YoY), and the FY2025 full-year result was -$155.0 million, down 100.4% from the prior year.
- Enterprise Value for Q1 2026 stood at -$146.7 million, up from -$155.0 million in the prior quarter.
- The five-year high for Enterprise Value was -$49.1 million in Q2 2024, with the low at -$155.0 million in Q4 2025.
- Average Enterprise Value over 5 years is -$84.7 million, with a median of -$77.1 million recorded in 2025.
- Peak annual rise in Enterprise Value reached 53.42% in 2022, while the deepest fall reached 173.27% in 2022.
- Tracing RIGL's Enterprise Value over 5 years: stood at -$58.2 million in 2022, then rose by 2.19% to -$56.9 million in 2023, then tumbled by 35.81% to -$77.3 million in 2024, then slumped by 100.4% to -$155.0 million in 2025, then rose by 5.34% to -$146.7 million in 2026.
- The last three Enterprise Value figures came in at -$146.7 million (Q1 2026), -$155.0 million (Q4 2025), and -$137.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | -146.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -146.68 Mn |
| Dec 31, 2025 | -154.96 Mn |
| Sep 30, 2025 | -137.14 Mn |
| Jun 30, 2025 | -108.38 Mn |
| Mar 31, 2025 | -77.10 Mn |
| Dec 31, 2024 | -77.32 Mn |
| Sep 30, 2024 | -61.11 Mn |
| Jun 30, 2024 | -49.10 Mn |
| Mar 31, 2024 | -49.55 Mn |
| Dec 31, 2023 | -56.93 Mn |
| Sep 30, 2023 | -62.35 Mn |
| Jun 30, 2023 | -64.36 Mn |
| Mar 31, 2023 | -58.66 Mn |
| Dec 31, 2022 | -58.21 Mn |
| Sep 30, 2022 | -81.64 Mn |
| Jun 30, 2022 | -89.17 Mn |
| Mar 31, 2022 | -107.52 Mn |
| Dec 31, 2021 | -124.97 Mn |
| Sep 30, 2021 | -143.15 Mn |
| Jun 30, 2021 | -153.39 Mn |
| Mar 31, 2021 | -39.35 Mn |
| Dec 31, 2020 | -57.33 Mn |
| Sep 30, 2020 | -72.81 Mn |
| Jun 30, 2020 | -92.50 Mn |
| Mar 31, 2020 | -95.93 Mn |
| Dec 31, 2019 | -98.08 Mn |
| Sep 30, 2019 | -107.48 Mn |
| Jun 30, 2019 | -112.38 Mn |
| Mar 31, 2019 | -127.92 Mn |
| Dec 31, 2018 | -128.54 Mn |
| Sep 30, 2018 | -115.64 Mn |
| Jun 30, 2018 | -134.99 Mn |
| Mar 31, 2018 | -94.30 Mn |
| Dec 31, 2017 | -115.75 Mn |
| Sep 30, 2017 | -68.08 Mn |
| Jun 30, 2017 | -82.30 Mn |
| Mar 31, 2017 | -98.14 Mn |
| Dec 31, 2016 | -74.77 Mn |
| Sep 30, 2016 | -85.26 Mn |
| Jun 30, 2016 | -94.94 Mn |
| Mar 31, 2016 | -103.63 Mn |
| Dec 31, 2015 | -126.28 Mn |
| Sep 30, 2015 | -134.35 Mn |
| Jun 30, 2015 | -143.94 Mn |
| Mar 31, 2015 | -161.16 Mn |
| Dec 31, 2014 | -143.16 Mn |
| Sep 30, 2014 | -157.67 Mn |
| Jun 30, 2014 | -176.03 Mn |
| Mar 31, 2014 | -195.38 Mn |
| Dec 31, 2013 | -211.98 Mn |
| Sep 30, 2013 | -230.88 Mn |
| Jun 30, 2013 | -251.64 Mn |
| Mar 31, 2013 | -272.45 Mn |
| Dec 31, 2012 | -298.24 Mn |
| Sep 30, 2012 | -183.90 Mn |
| Jun 30, 2012 | -202.64 Mn |
| Mar 31, 2012 | -223.30 Mn |
| Dec 31, 2011 | -247.64 Mn |
| Sep 30, 2011 | -265.68 Mn |
| Jun 30, 2011 | -279.10 Mn |
| Mar 31, 2011 | -25.71 Mn |
| Dec 31, 2010 | -177.30 Mn |
| Sep 30, 2010 | -22.06 Mn |
| Jun 30, 2010 | -32.23 Mn |